Deferred Tax Assets, Operating Loss Carryforwards of ABVC BIOPHARMA, INC. from 30 Sep 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary
ABVC BIOPHARMA, INC. quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD history and change rate from 30 Sep 2011 to 31 Dec 2025.
  • ABVC BIOPHARMA, INC. Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending 31 Dec 2025 was $6,473,705, a 14% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Change (%)

ABVC BIOPHARMA, INC. Quarterly Deferred Tax Assets, Operating Loss Carryforwards (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $6,473,705 +$796,292 +14% 31 Dec 2025 10-K 03 Mar 2026 2025 FY
Q3 2025 $5,995,850 30 Sep 2025 10-Q/A 03 Mar 2026 2025 Q3
Q2 2025 $6,048,501 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q4 2024 $5,677,413 31 Dec 2024 10-K 03 Mar 2026 2025 FY
Q4 2015 $75,689 +$50,629 +202% 31 Dec 2015 10-Q 23 Feb 2016 2016 Q1
Q3 2015 $85,516 +$62,281 +268% 30 Sep 2015 10-K 27 Nov 2015 2015 FY
Q2 2015 $24,646 30 Jun 2015 10-Q 19 Aug 2015 2015 Q3
Q1 2015 $25,900 31 Mar 2015 10-Q 05 Jun 2015 2015 Q2
Q4 2014 $25,060 +$25,060 31 Dec 2014 10-Q 23 Feb 2016 2016 Q1
Q3 2014 $23,235 +$23,235 30 Sep 2014 10-K 27 Nov 2015 2015 FY
Q4 2013 $0 31 Dec 2013 10-Q 17 Apr 2015 2015 Q1
Q3 2013 $0 -$5,535,327 -100% 30 Sep 2013 10-K 17 Apr 2015 2014 FY
Q3 2012 $5,535,327 +$1,069,379 +24% 30 Sep 2012 10-K 16 Apr 2015 2013 FY
Q3 2011 $4,465,948 30 Sep 2011 10-K 15 Apr 2015 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.